Maria Palasis's most recent trade in Lyra Therapeutics Inc was a trade of 1,565 Common Stock done at an average price of $8.9 . Disclosure was reported to the exchange on July 10, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Lyra Therapeutics Inc | Maria Palasis | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 8.91 per share. | 10 Jul 2025 | 1,565 | 1,098,435 | - | 8.9 | 13,944 | Common Stock |
| Beta Bionics Inc. | Maria Palasis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2025 | 11,247 | 11,247 | - | 0 | Common Stock | |
| Beta Bionics Inc. | Maria Palasis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2025 | 9,137 | 9,137 | - | - | Director Stock Option (right to buy) | |
| Lyra Therapeutics Inc | Maria Palasis | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Dec 2024 | 183,333 | 183,333 | - | - | Employee Stock Option (right to buy) | |
| Lyra Therapeutics Inc | Maria Palasis | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Oct 2024 | 300,000 | 300,000 | - | 0 | Common Stock | |
| Lyra Therapeutics Inc | Maria Palasis | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Mar 2024 | 500,000 | 500,000 | - | - | Stock Option | |
| Lyra Therapeutics Inc | Maria Palasis | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 150,000 | 150,000 | - | - | Stock Option | |
| Lyra Therapeutics Inc | Maria Palasis | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2023 | 250,000 | 250,000 | - | - | Stock Option | |
| Lyra Therapeutics Inc | Maria Palasis | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2022 | 175,000 | 175,000 | - | - | Stock Option | |
| Lyra Therapeutics Inc | Maria Palasis | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2022 | 127,400 | 127,400 | - | - | Stock Option | |
| Lyra Therapeutics Inc | Maria Palasis | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2021 | 120,000 | 120,000 | - | - | Stock Option |